Ultra-high-field arterial spin labeling MRI for non-contrast assessment of cortical lesion perfusion in multiple sclerosis by Drury, Richard J. et al.
MAGNETIC RESONANCE
Ultra-high-field arterial spin labelling MRI for non-contrast assessment
of cortical lesion perfusion in multiple sclerosis
Richard J. Dury1 & Yasser Falah2 & Penny A. Gowland1 & Nikos Evangelou2 & Molly G. Bright1,2,3,4 & Susan T. Francis1
Received: 2 March 2018 /Revised: 9 July 2018 /Accepted: 6 August 2018
# The Author(s) 2018
Abstract
Objectives To assess the feasibility of using an optimised ultra-high-field high-spatial-resolution low-distortion arterial spin
labelling (ASL) MRI acquisition to measure focal haemodynamic pathology in cortical lesions (CLs) in multiple sclerosis (MS).
Methods Twelve MS patients (eight female, mean age 50 years; range 35–64 years) gave informed consent and were scanned on
a 7 Tesla Philips Achieva scanner. Perfusion data were collected at multiple post-labelling delay times using a single-slice flow-
sensitive alternating inversion recovery ASL protocol with a balanced steady-state free precession readout scheme. CLs were
identified using a high-resolution Phase-Sensitive Inversion Recovery (PSIR) scan. Significant differences in perfusion within
CLs compared to immediately surrounding normal appearing grey matter (NAGMlocal) and total cortical normal appearing grey
matter (NAGMcortical) were assessed using paired t-tests.
Results Forty CLs were identified in PSIR scans that overlapped with the ASL acquisition coverage. After excluding lesions due
to small size or intravascular contamination, 27 lesions were eligible for analysis. Mean perfusion was 40 ± 25 ml/100 g/min in
CLs, 53 ± 12 ml/100 g/min in NAGMlocal, and 53 ± 8 ml/100 g/min in NAGMcortical. CL perfusion was significantly reduced by
23 ± 9% (mean ± SE, p = 0.013) and 26 ± 9% (p = 0.006) relative to NAGMlocal and NAGMcortical perfusion, respectively.
Conclusion This is the first ASL MRI study quantifying CL perfusion in MS at 7 Tesla, demonstrating that an optimised ASL
acquisition is sensitive to focal haemodynamic pathology previously observed using dynamic susceptibility contrast MRI. ASL
requires no exogenous contrast agent, making it a more appropriate tool to monitor longitudinal perfusion changes in MS,
providing a new window to study lesion development.
Key Points
• Perfusion can be quantified within cortical lesions in multiple sclerosis using an optimised high spatial resolution arterial spin
Labelling MRI acquisition at ultra-high-field.
• The majority of cortical lesions assessed using arterial spin labelling are hypo-perfused compared to normal appearing grey
matter, in agreement with dynamic susceptibility contrast MRI literature.
• Arterial spin labelling MRI, which does not involve the injection of a contrast agent, is a safe and appropriate technique for
repeat scanning of an individual patient.
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ASL Arterial spin labelling
CL Cortical lesion
DSC Dynamic susceptibility contrast
FAIR Flow-sensitive alternating inversion
recovery
MRI Magnetic resonance imaging
MS Multiple sclerosis
NAGMcortical Normal appearing grey matter (cortical)
NAGMlocal Normal appearing grey matter (local)
PLD Post-labelling delay




Cortical lesions (CLs) in patients with multiple sclerosis (MS)
are associated with physical disability [1] and cognitive im-
pairment [2]; however, little is known about the formation and
development of CLs due to their typically small size [3] and
the insufficient sensitivity and spatial resolution offered by
conventional imaging modalities. Emerging techniques using
ultra-high-field magnetic resonance imaging (MRI) can sig-
nificantly improve the detection of CLs compared to 3 Tesla
(T) scanners [4], and can advance our understanding of how
these lesions develop or resolve over time [5].
Techniques including phase-sensitive inversion recovery
(PSIR) [6] and double inversion recovery (DIR) [7] can
identify CLs and track their structural development.
However, it is also desirable to understand changes in phys-
iology that may precede or dictate these overt structural
changes. To date, the haemodynamic changes within CLs
have been characterised using dynamic susceptibility con-
trast (DSC) MRI, revealing that local haemodynamics
change with the status of the lesion: chronic CLs in grey
matter exhibit reduced perfusion and cerebral blood volume
[8–10], whereas in acute lesions elevated cerebral blood
volume has been reported [8]. Reports of changes in perfu-
sion prior to lesion formation and contrast enhancement
[11] suggest that studies of local haemodynamics may pre-
dict such tissue damage, identifying a critical window for
intervention.
To characterise rapid changes during periods of disease
activity and CL development, patients must be scanned re-
peatedly and frequently. DSC MRI, although the clinical
gold-standard for assessing haemodynamic changes, is not
well suited to such longitudinal studies. Concerns over dose-
dependent deposition of gadolinium-based contrast agents in
the brain caution against frequent repeated exposure [12–15].
Arterial spin labelling (ASL) MRI provides an alternative
method for quantifying local tissue perfusion that requires no
injection of exogenous contrast. ASL has been successfully
used to measure perfusion deficits in cortical grey matter in
early stages of MS compared to healthy controls, demonstrat-
ing its clinical sensitivity [16]. CL perfusion has been exam-
ined using Pseudo-Continuous ASL at 3T and DSC data col-
lected to validate the results: there was poor agreement in
perfusion quantification between the methods, highlighting
the challenges in making robust ASL perfusion measurements
in small CLs compared to larger regions, especially at coarser
spatial resolution. The inherently low contrast-to-noise ratio of
ASL techniques is substantially improved when scanning at
ultra-high-field (here defined to be 7T) [17], allowing data to
be collected at higher spatial resolution. However, there are
numerous challenges when performing ASL at 7T that require
optimisation of the imaging protocol [18]. In this study, we
assess the feasibility of using an optimised, ultra-high-field,
high-spatial resolution, low-distortion ASL acquisition [19] to
quantify perfusion in chronic CLs, demonstrating proof of
concept that this technique is suitable for characterising local
haemodynamic pathology in MS.
Materials and methods
This cross-sectional prospective study was approved by the
local research ethics authority. Twelve patients with MS
were recruited after giving informed consent. All patients
were selected based on having known pre-existing chronic
CLs from scans of two prior studies [6, 20]. One of these
studies developed the PSIR technique for improved CL
detection [6] and the second examined the ‘central vein
sign’ in white matter lesions [20]; neither of these earlier
studies acquired ASL data or quantified perfusion. Both
studies completed prior to the end of December 2014.
Access to these earlier scans followed ethical guidelines
to which consent was given. All scanning for this study
took place between September and December 2015, at
least 8 months after identification of CLs. As such, all
CLs in this study are considered chronic.
The 12 recruited patients included seven relapsing-
remitting and five progressive (four primary progressive and
one secondary progressive) MS patients (eight male, four fe-
male; mean age 50 years (range 35–64); median Expanded
Disability Status Scale 4.5 (range 2.0–6.0)).
Magnetic resonance acquisition
MRI was performed on a 7T Philips Achieva scanner
(Philips Medical Systems, Best, The Netherlands) using
a 32-channel receive coil. Details of acquisition parame-
ters are provided in Table 1. To identify CLs, a whole-
head PSIR scan was performed using a tailored adiabatic
inversion pulse to ensure efficient inversion in areas of
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radio frequency (RF) inhomogeneities found at ultra-high
field [21]. The timings of the turbo field echo (TFE)
readouts were optimised to suppress the signal from
voxels containing equal amounts of grey and white mat-
ter, thus producing a clear observable boundary between
them [6]. The PSIR images were acquired at high spatial
resolution (0.6 mm isotropic) to minimise partial volume
effects in small CLs, allowing accurate boundary
detection.
ASL data were acquired using a flow-sensitive alternat-
ing inversion recovery (FAIR) ASL scheme with in-plane
pre-saturation using a WET (Water suppression Enhanced
through T1 effects) scheme and a sinc post-saturation
pulse. A balanced steady-state free precession (bSSFP)
readout was used to achieve high spatial resolution (1.2
× 1.2 × 3.0 mm3) with minimal distortions, essential for
accurate co-registration of small CLs. A single axial im-
aging slice was positioned to transect one or more CLs
identified from the PSIR acquisition. Single-phase ASL
data were collected at post-labelling delay (PLD) of
1,400 and 1,800 ms to determine tissue perfusion (50
label-control pairs were acquired at each PLD, bSSFP
readout collected using α/2 pulse at a time TR/2 before
a train of RF pulses with α of 50o to reach a steady state).
In addition, multi-phase ASL data were acquired using a
Look-Locker bSSFP readout (with flip angle α of 35°)
comprising eight PLDs of 200, 550, 900, 1,250, 1,600,
1,960, 2,300 and 2,650 ms (40 label-control pairs, to es-
timate arterial transit time and locate intravascular signal
contributions). An M0 image was acquired for both
single- and multi-phase bSSFP acquisitions to allow ab-
solute perfusion quantification.
Cortical lesion identification
CLs were identified from the PSIR modulus image during the
scanning session by a trained rater (YF) in order to position
the ASL slice appropriately. CLs were selected as any
hypointense demarcated lesions within the cortical ribbon, as
described by Mougin et al [6]. Masks were drawn around the
CLs usingMIPAV (Medical Imaging Processing Analysis and
Visualisation, CIT, NIH, Bethesda, MD, USA).
Image co-registration
The ASL and PSIR sequences were acquired back-to-
back, to minimise misalignments between these data ac-
quisitions. However, in three patients there was significant
movement between the ASL and PSIR scans. In order to
accurately locate the CLs in ASL data-space, the PSIR
data were co-registered to the ASL data. Due to the lim-
ited coverage of the ASL scan, automated co-registration
techniques were not appropriate. Instead, the PSIR slices
corresponding to the ASL slice were identified and cor-
rective rotations were applied manually as needed using
FSL FLIRT [22]. The CL masks were then co-registered
to the ASL data by applying these transformations.
ASL pre-processing
The ASL data were brain extracted and motion corrected
using 2D in-plane co-registration using FSL MCFLIRT [23],
and any label-control pairs that contained > 1.2 mm transla-
tional movement (the in-plane resolution of the ASL voxels)
were discarded. The label images were subtracted from the
corresponding control images, and these difference images
were averaged for each PLD using a Huber M-estimator to
remove outlier signals and generate robust perfusion-weighted
images [24].
Perfusion quantification
The base M0 images were co-registered to the average ASL
label image using FSL FLIRT. A T1 map was obtained by
Table 1 Scan acquisition parameters. Acquisition parameters for the Phase Sensitive Inversion Recovery (PSIR) 3D turbo field echo (TFE) scan, and
the single and multi-phase arterial spin labelling (ASL) scans with a balanced steady-state free precession (bSSFP) read-out
Parameter PSIR Single-phase ASL Multi-phase ASL
Readout 3D-TFE bSSFP bSSFP
Field of view (AP, RL, FH) 200 × 181 × 120 mm3 192 × 192 × 3 mm3 192 × 192 × 3 mm3
Voxel size (AP, RL, FH) 0.6 × 0.6 × 0.6 mm3 1.2 × 1.2 × 3.0 mm3 1.2 × 1.2 × 3.0 mm3
Echo time (TE) 6 ms 1.9 ms 1.9 ms
Repetition time (TR) 13 ms 3.8 ms 3.8 ms
Flip angle 8° 50° 35°
SENSE (AP, RL, FH) 2, 1, 2 1, 2.5, 1 1, 2.5, 1
Post-labelling delay (PLD) - 1,400 and 1,800 ms 200, 550, 900, 1,250, 1,600, 1,960, 2,300, 2,650 ms
Averages 1 50 40
Scan duration (mm:ss) 12:55 5:06 per PLD 6:40 all PLDs
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fitting the label images from the multi-phase ASL data to a
Look-Locker saturation recovery curve:
S ¼ M 0 1−α∙exp − t
T*1
  
where M0 is the equilibrium magnetisation, α is the saturation
efficiency, t is the time following saturation and T1* is the
apparent longitudinal relaxation. The true T1 can then be cal-





þ ln cosαð Þ
τ
where α is the flip angle and τ is the spacing of the Look-
Locker readouts (350 ms). The T1 of the arterial blood was
estimated by fitting an inversion recovery to the signal in the
sagittal sinus and correcting for oxygenation [25].
The multi-phase ASL data were fit to the model described
by Francis et al [25] to produce a transit time map. This meth-
od also fits for perfusion; however, the SNR of the multi-
phase ASL data is considerably lower than that of the single-
phase ASL data [26]. Thus, this transit time map, the T1 map,
and the fitted value for the T1 of arterial blood were used with
the averaged single-phase data in a model fit, as described by
Gardener et al [17], to quantify perfusion in ml/100 g tissue/
min. To optimise this fit, the starting parameters were chosen
by comparing the voxel-by-voxel ASL signal to a lookup table
of modelled ASL signals. Parameters producing the best esti-
mate (assessed using the sum of square differences) were used
to initialise a Nelder-Mead simplex direct search implemented
in MATLAB (The MathWorks, Inc., Natick, MA, USA).
CL perfusion was calculated by averaging the voxel-wise
perfusion values inside the CL mask. A mask of local normal
appearing grey matter (NAGMlocal) was created by dilating
the CL mask to a radius of 12 mm, then restricting this to a
grey matter mask obtained from segmenting the PSIR image
using FSL FAST. Themean perfusion value inside this region,
with the CL removed, was defined as NAGMlocal perfusion.
Finally, the average perfusion in total cortical normal
appearing grey matter (NAGMcortical) was also computed.
Lesion eligibility
Any CL with a volume of less than three ASL voxels (12.96
mm3) was discarded. As vascular crushing could not be ap-
plied in this bSSFP ASL acquisition, fitted perfusion values
were influenced by both perfusion and intravascular blood
flow contamination in the voxel. A histogram of
NAGMcortical perfusion values was created and fitted to a mix-
ture model of Gaussians (allowing for multiple undetermined
perfusion and inflow signal sources); any voxel containing a
‘perfusion’ peak value of five times greater than the
NAGMcortical perfusion peak was assumed to be dominated
by vascular inflow, and this was used to create a vascular
inflow mask. CLs overlapping with this mask were discarded.
Statistical comparison of CL and NAGM perfusion
Paired two-sample t-tests were used to determine differences
in perfusion (significance threshold p < 0.05). Statistical anal-
yses were performed using Minitab 17 Statistical Software
(2010) (State College, PA, USA: Minitab, Inc. (www.
minitab.com)).
Results
Data from two participants were discarded due to head move-
ment that moved CLs out of the ASL imaging volume. All
remaining acquisitions were of sufficient quality to extract
perfusion maps.
Cortical lesion identification
In total, 40 CLs were identified in the PSIR scans that over-
lapped with the ASL slice acquisition. After applying the eli-
gibility criteria, 27 of the 40 lesions remained for analysis
(67.5%); four contained vascular contamination (10%), eight
were below the volume threshold (20%) and one failed both
tests (2.5%) (Table 2). Examples of a PSIR image, perfusion-
weighted ASL image, and CL, NAGMlocal and NAGMcortical
masks are presented in Fig. 1a-c.
Perfusion in CLs
The mean perfusion was 40 ± 24 ml/100 g/min in CLs, 53 ±
12 ml/100 g/min in NAGMlocal, and 53 ± 8 ml/100 g/min in
NAGMcortical (Fig. 1d). When comparing perfusion inside a
given lesion to the associated NAGMlocal, CL perfusion was
significantly lower, by 23 ± 9% (mean ± standard error, p =
0.013), and significantly lower than NAGMcortical perfusion,
by 25 ± 9% (mean ± standard error, p = 0.006).
Discussion
To our knowledge, this is the first study measuring CL perfu-
sion in MS using ASL at 7T. The majority of CLs showed
hypoperfusion compared to NAGM, in line with the previous
study by Peruzzo et al using DSC MRI at 1.5T [9], demon-
strating that this optimised ultra-high-field ASL-MRI tech-
nique is sensitive to the expected pathological hypoperfusion.
This was an exploratory study aimed at using ASL with a
bSSFP acquisition scheme to collect high spatial resolution
data and minimal distortions, following on from its develop-
ment in healthy subjects [19]. However, this restricted the
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acquisition to single-slice coverage, limiting our ability to ro-
bustly compare widespread cortical perfusion differences in
patients compared to controls, and the clinical applicability of
our technique. We are currently examining the reproducibility
of 7T FAIR ASL with increased brain coverage using an
alternative 3D-EPI acquisition scheme, for the comparison
of perfusion measures inMS patients with controls. Using this
imaging protocol in a test-retest study, we have recently dem-
onstrated that 7T FAIR ASL cortical perfusion values are sim-
ilarly repeatable in both MS patients and matched control
subjects [27]. Based on this empirical evidence, we do not
expect FAIR ASL data quality to be systematically impaired
in studies of MS cohorts. In order to assess the repeatability of
highly focal perfusion values (e.g. the spatial scale of CLs) in
different control and patient cohorts, further technical devel-
opment is needed to simultaneously achieve high-resolution
data with whole-brain coverage by combining the bSSFP ac-
quisition with simultaneous multislice (SMS) methods.
The ASL PLDs used here were optimised for quantifying
perfusion in cortical grey matter, and both PLDs and spatial
resolution would need to be adjusted to achieve sufficient
contrast-to-noise ratio for robust quantification of white matter
perfusion, which is significantly lower than NAGM and has
been shown to be of the order of 16ml/100 g/min [28]. Further
generalisability of our observations is limited by the small
sample size and heterogeneous disease course within our co-
hort. We plan to apply this new imaging protocol to study CL
perfusion across the distinct MS subtypes to better understand
Fig. 1 a Axial phase sensitive
inversion recovery (PSIR) slice
containing a cortical lesion (CL)
indicated by the arrow. b Arterial
spin labelling (ASL) perfusion
map (ml/100 g/min) of slice
shown in a. c Binary mask of the
cortical lesion, local and cortical
normal-appearing grey matter
(NAGMlocal and NAGMcortical). d
Violin plot of perfusion within
CLs, NAGMlocal and
NAGMcortical with the mean
indicated (black line)
Table 2 Overview of identified cortical lesions (CLs)
Patient CLs Volume (mm3)
1 4 27.86†, 21.60†, 8.42*, 16.63
2 5 13.18†, 15.12, 47.09, 14.04
3 1 17.50
4 3 44.50, 17.50, 19.44
5 3 17.71, 30.02, 26.35
6 6 29.38, 8.64*, 17.93, 15.55, 6.48*, 21.17
7 4 22.03, 14.90, 25.49, 16.42
8 5 15.98, 15.34, 7.13*, 19.44, 15.98†
9 7 12.96, 7.56*, 8.86*, 8.86*, 8.42*, 14.26, 25.49
10 2 12.53*, 18.36
CLs (*) with a cortical volume less than 12.96 mm3 were discounted
from analysis, along with those CLs (†) that had large vessel
contamination
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variations in lesion development in this diverse patient group.
Finally, previous work has reported poor agreement between
ASL and DSC perfusion estimates in CLs at 3T [29], and we
are now seeking to validate our perfusion results derived from
ASL in MS patients with results obtained using DSC-MRI,
the clinical gold-standard technique [27].
Unlike DSC, ASL requires no exogenous contrast agent,
making it an appropriate tool to study dynamic perfusion
changes in MS. ASL-MRI may facilitate the study of CL
formation and development, to test new therapeutic strategies
and better understand the heterogeneous disease course in
MS.
Acknowledgements The authors thank Dr. Christopher Tench for helpful
discussion of analysis procedures.
Funding This work was supported by the Medical Research Council
(grant number 1367061). Additional support came from the University
of Nottingham Anne McLaren Fellowship programme.
Compliance with ethical standards
Guarantor The scientific guarantor of this publication is Professor
Susan Francis, PhD.
Conflict of interest The authors of this manuscript declare no relation-
ships with any companies whose products or services may be related to
the subject matter of the article.
Statistics and biometry No complex statistical methods were necessary
for this paper.
Informed consent Written informed consent was obtained from all pa-
tients in this study.
Ethical approval Institutional Review Board approval was obtained.
Study subjects or cohorts overlap All patients were selected based on
having known pre-existing chronic cortical lesions (CLs) from scans
of two prior studies. One of these studies developed the PSIR tech-
nique for improved CL detection and the second examined the ‘cen-
tral vein sign’ in white matter lesions; neither of these earlier studies
acquired arterial spin labelling data or quantified perfusion. Access





• Performed at one institution
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give appro-
priate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made.
References
1. Calabrese M, Poretto V, Favaretto A et al (2012) Cortical lesion
load associates with progression of disability in multiple sclerosis.
Brain 135(Pt 10):2952–2961
2. Calabrese M, Agosta F, Rinaldi F et al (2009) Cortical lesions and
atrophy associated with cognitive impairment in relapsing-
remitting multiple sclerosis. Arch Neurol 66(9):1144–1150
3. Pitt D, Boster A, Pei W et al (2010) Imaging cortical lesions in
multiple sclerosis with ultra-high-field magnetic resonance imag-
ing. Arch Neurol 67(7):812–818
4. Nielsen AS, Kinkel RP, Tinelli E, Benner T, Cohen-Adad J,
Mainero C (2012) Focal cortical lesion detection in multiple scle-
rosis: 3 Tesla DIR versus 7 Tesla FLASH-T2. J Magn Reson
Imaging 35(3):537–542
5. Aphiwatthanasumet K, Mougin O, Geades N et al (2018) A longi-
tudinal study of lesion evolution in multiple sclerosis using multi-
contrast 7T MRI, Proceedings of the 26th Annual Meeting of the
International Society for Magnetic Resonance in Medicine, Paris,
France
6. Mougin O, Abdel-Fahim R, Dineen R, Pitiot A, Evangelou N,
Gowland P (2016) Imaging graymatter with concomitant null point
imaging from the phase sensitive inversion recovery sequence.
Magn Reson Med 76(5):1512–1516
7. Geurts JJ, Pouwels PJ, Uitdehaag BM, Polman CH, Barkhof F,
Castelijns JA (2005) Intracortical lesions in multiple sclerosis: im-
proved detection with 3D double inversion-recovery MR imaging.
Radiology 236(1):254–260
8. Haselhorst R, Kappos L, Bilecen D et al (2000) Dynamic suscepti-
bility contrast MR imaging of plaque development in multiple scle-
rosis: application of an extended blood-brain barrier leakage cor-
rection. J Magn Reson Imaging 11(5):495–505
9. PeruzzoD, CastellaroM, CalabreseM et al (2013) Heterogeneity of
cortical lesions in multiple sclerosis: an MRI perfusion study. J
Cereb Blood Flow Metab 33(3):457–463
10. Hojjat SP, Kincal M, Vitorino R et al (2016) Cortical Perfusion
Alteration in Normal-Appearing Gray Matter Is Most Sensitive to
Disease Progression in Relapsing-Remitting Multiple Sclerosis.
AJNR Am J Neuroradiol 37(8):1454–1461
11. Wuerfel J, Bellmann-Strobl J, Brunecker P et al (2004) Changes in
cerebral perfusion precede plaque formation in multiple sclerosis: a
longitudinal perfusion MRI study. Brain 127(Pt 1):111–119
12. Radbruch A, Weberling LD, Kieslich PJ et al (2015) Gadolinium
retention in the dentate nucleus and globus pallidus is dependent on
the class of contrast agent. Radiology 275(3):783–791
13. McDonald RJ, McDonald JS, Kallmes DF et al (2015) Intracranial
Gadolinium Deposition after Contrast-enhanced MR Imaging.
Radiology 275(3):772–782
14. Kanda T, Fukusato T, Matsuda M et al (2015) Gadolinium-based
Contrast Agent Accumulates in the Brain Even in Subjects without
Severe Renal Dysfunction: Evaluation of AutopsyBrain Specimens
with Inductively Coupled Plasma Mass Spectroscopy. Radiology
276(1):228–232
15. Kanda T, Ishii K, Kawaguchi H, Kitajima K, Takenaka D (2014)
High signal intensity in the dentate nucleus and globus pallidus on
unenhanced T1-weighted MR images: relationship with increasing
cumulative dose of a gadolinium-based contrast material.
Radiology 270(3):834–841
16. Debernard L,Melzer TR, Van StockumS et al (2014) Reduced grey
matter perfusion without volume loss in early relapsing-remitting
multiple sclerosis. J Neurol Neurosurg Psychiatry 85(5):544–551
Eur Radiol
17. Gardener AG, Gowland PA, Francis ST (2009) Implementation of
quantitative perfusion imaging using pulsed arterial spin labeling at
ultra-high field. Magn Reson Med 61(4):874–882
18. Teeuwisse WM, Webb AG, van Osch MJ (2010) Arterial Spin
Labeling at Ultra-High Field: All That Glitters is Not Gold. Int J
Imaging Syst Technol. 20:62–70. https://doi.org/10.1002/ima.
20218
19. Hall EL, Wesolowski R, Gowland PA, Francis ST (2010)
Optimising image readout for perfusion imaging at 7T.
Proceedings of the 18th Annual Scientific Meeting and
Exhibition of the International Society for Magnetic Resonance in
Medicine, Stockholm, 1–7 May 2010
20. Samaraweera AP, Clarke MA, Whitehead A et al (2017) The
Central Vein Sign in Multiple Sclerosis Lesions Is Present
Irrespective of the T2* Sequence at 3 T. J Neuroimaging 27(1):
114–121
21. Hurley AC, Al-RadaidehA, Bai L et al (2010) Tailored RF pulse for
magnetization inversion at ultrahigh field. Magn ResonMed 63(1):
51–58
22. Jenkinson M, Bannister P, Brady M, Smith S (2002) Improved
Optimisation for the Robust and Accurate Linear Registration and
Motion Correction of Brain Images. Neuroimage 17(2):825–841
23. Smith SM (2002) Fast robust automated brain extraction. Hum
Brain Mapp 17(3):143–155
24. Maumet C,Maurel P, Ferré JC, Barillot C (2014) Robust estimation
of the cerebral blood flow in arterial spin labelling. Magn Reson
Imaging 32(5):497–504
25. Blockley NP, Jiang L, Gardener AG, Ludman CN, Francis ST,
Gowland PA (2008) Field strength dependence of R1 and R2*
relaxivities of human whole blood to ProHance, Vasovist, and
deoxyhemoglobin. Magn Reson Med 60(6):1313–1320
26. Francis ST, Bowtell R, Gowland PA (2008) Modeling and optimi-
zation of Look-Locker spin labeling for measuring perfusion and
transit time changes in activation studies taking into account arterial
blood volume. Magn Reson Med 59(2):316–325
27. Dury RJ, Falah Y, Gowland PA, Evangelou N, Francis ST, Bright
MG (2018) Reproducibility and quality assessment of a 3D-EPI
pulsed arterial spin labelling scheme at 7 T in a clinical cohort,
(abstract) Proc Intl Soc Magn Reson Med Ann Mtg Paris, France
28. Gardener AG, Jezzard P (2015) Investigating white matter perfu-
sion using optimal sampling strategy arterial spin labeling at 7
Tesla. Magn Reson Med 73(6):2243–2248
29. D'Ortenzio RM, Hojjat SP, Vitorino R et al (2016) Comparison of
Quantitative Cerebral Blood Flow Measurements Performed by
Bookend Dynamic Susceptibility Contrast and Arterial Spin-
Labeling MRI in Relapsing-Remitting Multiple Sclerosis. AJNR
Am J Neuroradiol 37(12):2265–2272
Eur Radiol
